02.1 D3 vs D2

Vitamin D3 vs D2: what the label and the assay change

Technical document 02.1 · Reviewed 2026-11-18 · Vitamin D3

On this page
  1. Two molecules, two starting materials
  2. The IU arithmetic is shared
  3. What the label has to name
  4. What the assay has to resolve
  5. The regulatory basis is form-specific
  6. Can one form replace the other?

Vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol) are different molecules with different sources, different molecular masses and different analytical standards. They share one thing: the labelling convention that gives 1 µg of either form 40 IU. The label has to name which molecule the product contains, and the assay has to be calibrated for that molecule rather than for “vitamin D” in general.

In one line

D3 and D2 share the IU arithmetic but not the molecule; the label must name which one, and the assay must be calibrated for it.

Two molecules, two starting materials

Cholecalciferol and ergocalciferol side by side
PropertyVitamin D3Vitamin D2
NameCholecalciferolErgocalciferol
Formula and massC27H44O · 384.64 g/molC28H44O · 396.65 g/mol
CAS67-97-050-14-6
Usual sourceLanolin cholesterol, or lichen, converted by UVErgosterol from yeast or fungi, converted by UV

Both forms occur in nature and both are made commercially by ultraviolet irradiation of a sterol precursor: 7-dehydrocholesterol for D3, ergosterol for D2. The source route belongs in the file because it drives the vegan statement and the allergen review. Lanolin-derived D3 is not vegan; lichen-derived D3 is the usual vegan option; D2 from yeast is generally accepted as vegan. None of this changes the molecule's identity, but it changes what the label and the customer specification have to say.

The IU arithmetic is shared

The IU is a unit of vitamin D activity, and the labelling convention assigns 40 IU to one microgram of cholecalciferol and to one microgram of ergocalciferol. A 10 µg dose is 400 IU, a 25 µg dose is 1,000 IU and a 100 µg dose is 4,000 IU, whichever of the two forms carries it. The conversion is not a statement that the two molecules behave identically in every respect; it is the arithmetic that the label uses.

This is why a potency comparison has to be read carefully. A D3 product is often described as more potent than a D2 product, but in labelling terms the two are assigned the same 40 IU per microgram, so a 25 µg D2 capsule and a 25 µg D3 capsule both declare 1,000 IU. A switch from one form to the other is a change of ingredient, not a rescaling of the dose. Any question about the effect of the two forms in the body is outside this page, which deals with identity, assay and label.

What the label has to name

In the EU, vitamin D is declared in micrograms per portion and as a percentage of the nutrient reference value of 5 µg (200 IU), and the ingredient list names the form that is present, cholecalciferol or ergocalciferol. In the US, the Supplement Facts panel declares vitamin D in micrograms against a Daily Value of 20 µg (800 IU), with the source in parentheses, for example “Vitamin D (as cholecalciferol)”; IU may be added after the microgram figure but is optional. The UK uses the EU-style declaration and the 5 µg reference value.

“Vitamin D3” is a specific name, not a synonym for vitamin D. A product made with ergocalciferol cannot be labelled as D3 or cholecalciferol, and a product made with cholecalciferol should not be described as D2. The form also belongs in the specification and on the certificate, because the label claim and the analytical standard have to point to the same molecule.

What the assay has to resolve

Cholecalciferol and ergocalciferol are close enough in their ultraviolet spectra that a method which reports a single “vitamin D” peak may not show which molecule it measured. A defensible assay runs a reference standard for the form named on the label, resolves the two peaks, and reports the result against the matching standard. Co-injection or a diode-array spectrum strengthens the assignment, and mass detection separates the two by molecular mass when the peaks overlap.

The certificate should name the standard, the column, the mobile phase and the wavelength, and it should state whether the other form was screened and at what detection limit. A D3 certificate is not a D2 certificate: the same IU/g figure can describe two different molecules, and only the chromatogram and the standard tell them apart. This is also why a supplier change from D3 to D2 requires a new specification and a new certificate, not a note on the old one.

The regulatory basis is form-specific

In the EU, Directive 2002/46/EC Annex II, Part A lists both cholecalciferol and ergocalciferol as permitted vitamin D sources, so either form can be used in a food supplement. In the US, both are dietary ingredients sold under DSHEA. In Great Britain, both are on the retained permitted-forms list. The permission attaches to the named form, which is why the label and the certificate have to name it.

The contaminant limits and the labelling rules are the same for both forms, and the claim route is the same: a claim has to be permitted for vitamin D in the market where the product is sold, and the supplier makes no claim for the ingredient. What changes between the forms is the ingredient name, the analytical standard and the source statement, not the permission to sell vitamin D.

Can one form replace the other?

In a formula, the two forms are not a like-for-like substitution. The dose arithmetic survives, because 40 IU per microgram applies to both, but the label, the specification, the supplier's certificate, the stability data and the source statement all change. A D2 lot cannot be released against a D3 specification, and a D3 lot cannot satisfy a label that names ergocalciferol.

If a form change is being considered, ask for the new certificate, the chromatogram with the matching standard and a stability summary for the new matrix. The vitamin D3 product page covers the cholecalciferol grade; the identity page sets out the four-layer proof; the COA page explains the assay and the carrier. The compliance page covers the market file, and the HPLC method note describes the separation.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation